The solution is administered intramuscularly or intravenously.
In connection with the fact that different schemes of application of Leucovorin-LENS® are used when choosing a specific dose, the physician should be guided by special medical literature.
All the below listed doses are given in accordance with the conversion to folinic acid.
Usually when the drug is administered in combination with high doses of methotrexate (12-15 g / m2) the administration begins 24 hours after the end of treatment with methotrexate at a dose of 10 mg / m2 every 6 hours for 72 hours or until the methotrexate concentration in the blood plasma is less than 5x10 ~8 M.
In patients with acidic urine reaction, exudative effusions, impaired renal function, intestinal obstruction, a higher dose of Leucovorin-LENS® and / or longer duration of treatment may be required, since the excretion of methotrexate in this group of patients may be delayed. The use of leucovorin-LENS® in these cases is recommended to be based on the mandatory determination of the concentration of methotrexate in the blood plasma. To prevent the development of chronic renal failure, hydration (3 L / day) is performed and administered sodium hydrogen carbonate to maintain the pH of urine at 7 or higher.
At random overdose of methotrexate Leucovorin-LENS® is administered at a dose equal to or greater than the dose of methotrexate administered no later than 1 hour after injection of methotrexate, then the drug is administered every 3 hours to 10 mg / m2 until the disappearance of signs of toxicity.
When combined with fluorouracil Leucovorin-LENS® is administered:
- in a dose of 200 mg / m2 intravenously slowly (at least 3 minutes) or intravenously drip followed by intravenous fluorouracil at a dose of 370 mg / m2 or
- in a dose of 20 mg / m2 intravenously followed by intravenous administration of fluorouracil at a dosage of 425 mg / m2
The drugs are administered daily for 5 days at intervals of 4-5 weeks between repeated courses.
In the treatment megaloblastic anemia caused by a deficiency of folic acid Leucovorin-LENS® is prescribed for 1 mg intramuscularly or intravenously per day.